
The FDA is expected to authorize a third dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines for immunocompromised patients; the CDC revised its COVID-19 vaccine guidance to include pregnant individuals; the FDA issued a complete response letter for the once-anticipated anemia drug roxadustat.





























